Centessa Pharmaceuticals plc (260.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
| Previous Close | 8.45 |
| Open | 8.50 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's Range | 8.50 - 8.50 |
| 52 Week Range | 3.82 - 11.20 |
| Volume | |
| Avg. Volume | 4 |
| Market Cap | 949.127M |
| Beta (5Y Monthly) | 1.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Centessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Results
Aligning with EPS Projections, CNTA Reports a Net Loss Decrease in Q4
- GuruFocus.com
Centessa Pharmaceuticals PLC Chief People Officer Sells Company Shares
Karen Anderson, the Chief People Officer of Centessa Pharmaceuticals PLC (NASDAQ:CNTA), has sold 51,160 shares of the company on March 25, 2024, according to a recent SEC Filing.
- Simply Wall St.
Private equity firms who have a significant stake must be disappointed along with institutions after Centessa Pharmaceuticals plc's (NASDAQ:CNTA) market cap dropped by US$139m
Key Insights The considerable ownership by private equity firms in Centessa Pharmaceuticals indicates that they...
© 2024 Yahoo. All rights reserved.